Warren, NJ - The Food and Drug Administration has granted 510(k) clearance to Cordis Endovascular to market the OPTEASE TM vena cava retrievable filter. The filter is designed to be percutaneously ...
(HealthDay)—For patients with acute, symptomatic pulmonary embolism, the use of retrievable vena cava filters with anticoagulation does not offer any benefit over anticoagulation alone, according to a ...
Optional vena cava filters can used to provide either short-term or permanent protection from pulmonary embolism. These devices have recently become available for clinical use in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results